Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Birch

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Antimicrobial Chemotherapy|May 23, 2018
Efficacy of bezlotoxumab based on timing of administration relative to start of antibacterial therapy for Clostridium difficile infectionThomas Birch, Yoav Golan, Giuliano Rizzardini, et al.
Emerging Infectious Diseases|March 20, 2004
SARS and pregnancy: a case reportCorwin A Robertson, Sara A Lowther, Thomas Birch, et al.
Open Forum Infectious Diseases|February 27, 2020
Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With <i>Clostridioides difficile</i> Infection in MODIFY I/II Participants With CancerOliver A Cornely, Kathleen M Mullane, Thomas Birch, et al.
Critical Care Explorations|September 28, 2020
Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019Ravit Barkama, Ami Mayo, Alona Paz, et al.
The New England Journal of Medicine|January 26, 2017
Bezlotoxumab for Prevention of Recurrent Clostridium difficile InfectionMark H Wilcox, Dale N Gerding, Ian R Poxton, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Antimicrobial Chemotherapy|May 23, 2018
Efficacy of bezlotoxumab based on timing of administration relative to start of antibacterial therapy for Clostridium difficile infectionThomas Birch, Yoav Golan, Giuliano Rizzardini, et al.
Emerging Infectious Diseases|March 20, 2004
SARS and pregnancy: a case reportCorwin A Robertson, Sara A Lowther, Thomas Birch, et al.
Open Forum Infectious Diseases|February 27, 2020
Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With <i>Clostridioides difficile</i> Infection in MODIFY I/II Participants With CancerOliver A Cornely, Kathleen M Mullane, Thomas Birch, et al.
Critical Care Explorations|September 28, 2020
Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019Ravit Barkama, Ami Mayo, Alona Paz, et al.
The New England Journal of Medicine|January 26, 2017
Bezlotoxumab for Prevention of Recurrent Clostridium difficile InfectionMark H Wilcox, Dale N Gerding, Ian R Poxton, et al.
Pageof 1